France's Sanofi buys US hemophilia specialist Bioverativ

France-based drugmaker Sanofi is buying U.S. hemophilia specialist Bioverativ for $11.6 billion in a deal that Sanofi says will boost its profile for fighting rare diseases.

     

 

 

from USATODAY - News Top Stories http://ift.tt/2Bja4uJ